Solubilization and Characterization of Muscarinic Acetylcholine Receptors View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

1984

AUTHORS

E. C. Hulme , N. J. M. Birdsall , C. P. Berrie , T. Haga , J. M. Stockton

ABSTRACT

Three distinct types of detergent have been found to be capable of solubilizing muscarinic binding activity from the rat forebrain. These are: (a) the alkylpolyoxyethylenes such as Lubrol PX [1]; (b) steroids such as cholate [2, 3], digitonin [4, 5] and the cholate sulphobetaine derivative CHAPS [6]; and (c) lysophosphatidylcholine [7]. In such studies, it has proved convenient to compare the overall yield of solubilized receptors from brain membranes (P2 and P3) pre-labelled with the irreversible alkylating affinity label [3H]propylbenzilylcholine (3H-PrBCM) [8] with the yield of active binding sites which can be assayed in the supernatant after extraction of non-pre-labelled membranes. Solubilized binding sites were conveniently measured by incubating 600,000 g-min supernatants with receptor-saturating concentrations (3 × 10-8 M) of (-)-N-[Me-3H]- scopolamine (3H-NMS) or (-)-[3H]quinuclidinyl-benzilate (3H-QNB), followed by separation of bound from free ligand by rapid gel filtration on small columns of Sephadex G-50 M [3]. More... »

PAGES

421-423

Book

TITLE

Investigation of Membrane-Located Receptors

ISBN

978-1-4684-4633-3
978-1-4684-4631-9

Author Affiliations

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46

DOI

http://dx.doi.org/10.1007/978-1-4684-4631-9_46

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1021187127


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hulme", 
        "givenName": "E. C.", 
        "id": "sg:person.01261741527.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261741527.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Birdsall", 
        "givenName": "N. J. M.", 
        "id": "sg:person.011475722264.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011475722264.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berrie", 
        "givenName": "C. P.", 
        "id": "sg:person.0764457447.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764457447.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haga", 
        "givenName": "T.", 
        "id": "sg:person.01032572647.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032572647.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Francis Crick Institute", 
          "id": "https://www.grid.ac/institutes/grid.451388.3", 
          "name": [
            "Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stockton", 
        "givenName": "J. M.", 
        "id": "sg:person.01215134447.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215134447.17"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0003-9861(78)90296-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001676105"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.77.11.6368", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002238097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-5793(78)81063-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003866577"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1476-5381.1979.tb13685.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028880890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(82)90694-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048475112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(82)90694-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048475112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-5793(80)80497-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048905138"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1476-5381.1974.tb09658.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052318019"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1984", 
    "datePublishedReg": "1984-01-01", 
    "description": "Three distinct types of detergent have been found to be capable of solubilizing muscarinic binding activity from the rat forebrain. These are: (a) the alkylpolyoxyethylenes such as Lubrol PX [1]; (b) steroids such as cholate [2, 3], digitonin [4, 5] and the cholate sulphobetaine derivative CHAPS [6]; and (c) lysophosphatidylcholine [7]. In such studies, it has proved convenient to compare the overall yield of solubilized receptors from brain membranes (P2 and P3) pre-labelled with the irreversible alkylating affinity label [3H]propylbenzilylcholine (3H-PrBCM) [8] with the yield of active binding sites which can be assayed in the supernatant after extraction of non-pre-labelled membranes. Solubilized binding sites were conveniently measured by incubating 600,000 g-min supernatants with receptor-saturating concentrations (3 \u00d7 10-8 M) of (-)-N-[Me-3H]- scopolamine (3H-NMS) or (-)-[3H]quinuclidinyl-benzilate (3H-QNB), followed by separation of bound from free ligand by rapid gel filtration on small columns of Sephadex G-50 M [3].", 
    "editor": [
      {
        "familyName": "Reid", 
        "givenName": "Eric", 
        "type": "Person"
      }, 
      {
        "familyName": "Cook", 
        "givenName": "G. M. W.", 
        "type": "Person"
      }, 
      {
        "familyName": "Morr\u00e9", 
        "givenName": "D. J.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-4684-4631-9_46", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-1-4684-4633-3", 
        "978-1-4684-4631-9"
      ], 
      "name": "Investigation of Membrane-Located Receptors", 
      "type": "Book"
    }, 
    "name": "Solubilization and Characterization of Muscarinic Acetylcholine Receptors", 
    "pagination": "421-423", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-4684-4631-9_46"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "64f1f630075d4a3390a35b45afb0e193bcb2bd20aed9b5cce00fcd7630594a3e"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1021187127"
        ]
      }
    ], 
    "publisher": {
      "location": "Boston, MA", 
      "name": "Springer US", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-4684-4631-9_46", 
      "https://app.dimensions.ai/details/publication/pub.1021187127"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T00:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8700_00000256.jsonl", 
    "type": "Chapter", 
    "url": "http://link.springer.com/10.1007/978-1-4684-4631-9_46"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-4684-4631-9_46'


 

This table displays all metadata directly associated to this object as RDF triples.

124 TRIPLES      23 PREDICATES      34 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-4684-4631-9_46 schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author Ne8ec34658fe24a8bac2e5453b9cdd2ec
4 schema:citation https://doi.org/10.1016/0003-9861(78)90296-5
5 https://doi.org/10.1016/0006-2952(82)90694-3
6 https://doi.org/10.1016/0014-5793(78)81063-1
7 https://doi.org/10.1016/0014-5793(80)80497-2
8 https://doi.org/10.1073/pnas.77.11.6368
9 https://doi.org/10.1111/j.1476-5381.1974.tb09658.x
10 https://doi.org/10.1111/j.1476-5381.1979.tb13685.x
11 schema:datePublished 1984
12 schema:datePublishedReg 1984-01-01
13 schema:description Three distinct types of detergent have been found to be capable of solubilizing muscarinic binding activity from the rat forebrain. These are: (a) the alkylpolyoxyethylenes such as Lubrol PX [1]; (b) steroids such as cholate [2, 3], digitonin [4, 5] and the cholate sulphobetaine derivative CHAPS [6]; and (c) lysophosphatidylcholine [7]. In such studies, it has proved convenient to compare the overall yield of solubilized receptors from brain membranes (P2 and P3) pre-labelled with the irreversible alkylating affinity label [3H]propylbenzilylcholine (3H-PrBCM) [8] with the yield of active binding sites which can be assayed in the supernatant after extraction of non-pre-labelled membranes. Solubilized binding sites were conveniently measured by incubating 600,000 g-min supernatants with receptor-saturating concentrations (3 × 10-8 M) of (-)-N-[Me-3H]- scopolamine (3H-NMS) or (-)-[3H]quinuclidinyl-benzilate (3H-QNB), followed by separation of bound from free ligand by rapid gel filtration on small columns of Sephadex G-50 M [3].
14 schema:editor N83398220c7894eb7b556d8b55aa7c656
15 schema:genre chapter
16 schema:inLanguage en
17 schema:isAccessibleForFree false
18 schema:isPartOf N9c5a50362a714793a46a2c9cd43b15e5
19 schema:name Solubilization and Characterization of Muscarinic Acetylcholine Receptors
20 schema:pagination 421-423
21 schema:productId N554405a39484406d9b380d163e0ba4b5
22 N95efbbd6d88e4113b24e0d0e9efe2c03
23 Nd0253f9e8c62415f8dd3aa692fbfc822
24 schema:publisher N4e9b62cdb2624046822d2cd9c2304aa2
25 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021187127
26 https://doi.org/10.1007/978-1-4684-4631-9_46
27 schema:sdDatePublished 2019-04-16T00:48
28 schema:sdLicense https://scigraph.springernature.com/explorer/license/
29 schema:sdPublisher Naba8a6e16cb949c2a69f42f39804ecff
30 schema:url http://link.springer.com/10.1007/978-1-4684-4631-9_46
31 sgo:license sg:explorer/license/
32 sgo:sdDataset chapters
33 rdf:type schema:Chapter
34 N10f4a9a0822444f495722ec7fd1fafb9 rdf:first sg:person.01032572647.74
35 rdf:rest N1c8c898b6fa54b53962a751d4f2a70e8
36 N1128b5d8dc8644e684f58959507c84d2 rdf:first sg:person.011475722264.08
37 rdf:rest N90b4a1e52df54a74b9e37324e015e9d1
38 N1c8c898b6fa54b53962a751d4f2a70e8 rdf:first sg:person.01215134447.17
39 rdf:rest rdf:nil
40 N239d2e3aa492462ca346cc13cce90c01 schema:familyName Morré
41 schema:givenName D. J.
42 rdf:type schema:Person
43 N26e860e722ff47118daf8bf6ab505514 schema:familyName Reid
44 schema:givenName Eric
45 rdf:type schema:Person
46 N4e9b62cdb2624046822d2cd9c2304aa2 schema:location Boston, MA
47 schema:name Springer US
48 rdf:type schema:Organisation
49 N554405a39484406d9b380d163e0ba4b5 schema:name readcube_id
50 schema:value 64f1f630075d4a3390a35b45afb0e193bcb2bd20aed9b5cce00fcd7630594a3e
51 rdf:type schema:PropertyValue
52 N7fec35becbae44b9b2bac28376350d8c rdf:first Ne304a0a96f204f1f8436e7bf8af8dd6a
53 rdf:rest Neea8c7c00bd14d7db20f8f39346d2e7c
54 N83398220c7894eb7b556d8b55aa7c656 rdf:first N26e860e722ff47118daf8bf6ab505514
55 rdf:rest N7fec35becbae44b9b2bac28376350d8c
56 N90b4a1e52df54a74b9e37324e015e9d1 rdf:first sg:person.0764457447.89
57 rdf:rest N10f4a9a0822444f495722ec7fd1fafb9
58 N95efbbd6d88e4113b24e0d0e9efe2c03 schema:name doi
59 schema:value 10.1007/978-1-4684-4631-9_46
60 rdf:type schema:PropertyValue
61 N9c5a50362a714793a46a2c9cd43b15e5 schema:isbn 978-1-4684-4631-9
62 978-1-4684-4633-3
63 schema:name Investigation of Membrane-Located Receptors
64 rdf:type schema:Book
65 Naba8a6e16cb949c2a69f42f39804ecff schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 Nd0253f9e8c62415f8dd3aa692fbfc822 schema:name dimensions_id
68 schema:value pub.1021187127
69 rdf:type schema:PropertyValue
70 Ne304a0a96f204f1f8436e7bf8af8dd6a schema:familyName Cook
71 schema:givenName G. M. W.
72 rdf:type schema:Person
73 Ne8ec34658fe24a8bac2e5453b9cdd2ec rdf:first sg:person.01261741527.53
74 rdf:rest N1128b5d8dc8644e684f58959507c84d2
75 Neea8c7c00bd14d7db20f8f39346d2e7c rdf:first N239d2e3aa492462ca346cc13cce90c01
76 rdf:rest rdf:nil
77 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
78 schema:name Medical and Health Sciences
79 rdf:type schema:DefinedTerm
80 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
81 schema:name Pharmacology and Pharmaceutical Sciences
82 rdf:type schema:DefinedTerm
83 sg:person.01032572647.74 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
84 schema:familyName Haga
85 schema:givenName T.
86 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032572647.74
87 rdf:type schema:Person
88 sg:person.011475722264.08 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
89 schema:familyName Birdsall
90 schema:givenName N. J. M.
91 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011475722264.08
92 rdf:type schema:Person
93 sg:person.01215134447.17 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
94 schema:familyName Stockton
95 schema:givenName J. M.
96 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215134447.17
97 rdf:type schema:Person
98 sg:person.01261741527.53 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
99 schema:familyName Hulme
100 schema:givenName E. C.
101 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261741527.53
102 rdf:type schema:Person
103 sg:person.0764457447.89 schema:affiliation https://www.grid.ac/institutes/grid.451388.3
104 schema:familyName Berrie
105 schema:givenName C. P.
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0764457447.89
107 rdf:type schema:Person
108 https://doi.org/10.1016/0003-9861(78)90296-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001676105
109 rdf:type schema:CreativeWork
110 https://doi.org/10.1016/0006-2952(82)90694-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048475112
111 rdf:type schema:CreativeWork
112 https://doi.org/10.1016/0014-5793(78)81063-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003866577
113 rdf:type schema:CreativeWork
114 https://doi.org/10.1016/0014-5793(80)80497-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048905138
115 rdf:type schema:CreativeWork
116 https://doi.org/10.1073/pnas.77.11.6368 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002238097
117 rdf:type schema:CreativeWork
118 https://doi.org/10.1111/j.1476-5381.1974.tb09658.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1052318019
119 rdf:type schema:CreativeWork
120 https://doi.org/10.1111/j.1476-5381.1979.tb13685.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028880890
121 rdf:type schema:CreativeWork
122 https://www.grid.ac/institutes/grid.451388.3 schema:alternateName The Francis Crick Institute
123 schema:name Division of Molecular Pharmacology, National Institute for Medical Research, Mill Hill, London, NW7 1AA, UK
124 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...